Trademark: 97545141
Word
TASOQLIR
Status
Pending
Status Code
686
Status Date
Tuesday, March 12, 2024
Serial Number
97545141
Mark Type
4000
Filing Date
Thursday, August 11, 2022
Published for Opposition
Tuesday, March 12, 2024

Trademark Owner History
Glaxo Group Limited - Owner At Publication

Classifications
5 Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Events
Mar 12, 2024
Official Gazette Publication Confirmation E-Mailed
Mar 12, 2024
Published For Opposition
Feb 21, 2024
Notification Of Notice Of Publication E-Mailed
Feb 21, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 7, 2024
Approved For Pub - Principal Register
Jan 10, 2024
Suspension Checked - To Attorney For Action
Sep 28, 2023
Teas Response To Suspension Inquiry Received
Jul 12, 2023
Teas Change Of Correspondence Received
Jul 12, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 12, 2023
Teas Change Of Owner Address Received
Jun 1, 2023
Notification Of Letter Of Suspension E-Mailed
Jun 1, 2023
Letter Of Suspension E-Mailed
Jun 1, 2023
Suspension Letter Written
May 30, 2023
Assigned To Examiner
Aug 17, 2022
New Application Office Supplied Data Entered
Aug 15, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24